Health Care: Drugs

Valeant Pharmaceuticals International Inc (VRX: NYSE)

$116.98 -0.45 | -0.38%
09/22/14 - 10:46 AM ET
Company Profile
Price and Volume
Recent Price 117.43
52 Week High 153.10
52 Week Low 102.30
Avg. Daily Vol. (Mil) 2.43
Beta (3 year) 0.96
Share Related Items
Mkt Cap (Mil) 39,387.32
Shares Out (Mil) 335.41
Float (Mil) 273.36
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.90
Current Ratio 2.10
LT Debt/ Equity 3.24
Total Debt / Equity 3.30
Valuation Ratios
Price Earnings n.a.
Price/Sales 5.23
Price/Book 7.49
Price/Cash Flow 26.40
Per Share Data
Earnings -2.19
Sales 22.46
Book Value 15.68
Cash Flow 4.44
Business Summary
Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company that develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.
General Information
2150 Street Elzar Boulevard
Laval, QC H7L 4A8B
www.valeant.com
Industry : Drugs
Sector: Health Care
Employees: 17200
CEO: J. Michael Pearson
Short Interest
Current Month (Mil) 13.17
Previous Month (Mil) 13.14
Short Interest Ratio (Days) 4.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -2.70
Return on Investments -3.30
Profitability
Gross Margin 71.20
EBIT Margin -1.20
Profit Margin -9.90

Portfolios with VRX

Latest VRX Headlines from TheStreet

More Financial News for VRX

Press Releases for VRX

See All Press Releases

Partner Headlines for VRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter